Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-10-2007 | Editorial commentary

PET probes and oncological surgery: a productive new marriage for nuclear medicine?

Author: Orazio Schillaci

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 10/2007

Excerpt

Surgical excision is still the best option in attempting to cure many solid cancers. Even patients with tumours that have already metastasised to regional lymph nodes or to distant sites are potential candidates for surgery [1]. With this in mind, accurate staging of the disease and detection of all cancer sites are of the utmost importance in order to allow selection of those patients who may really benefit from complete surgical resection. …

Essner R, Daghighian F, Giuliano AE. Advances in FDG PET probes in surgical oncology. Cancer J 2002;8:100–8.PubMedCrossRef

Endo K, Oriuchi N, Higuchi T, Iida Y, Hanaoka H, Miyakubo M, et al. PET and PET/CT using ¹⁸F-FDG in the diagnosis and management of cancer patients. Int J Clin Oncol 2006;11:286–96.PubMedCrossRef

Blodgett TM, Meltzer CC, Townsend DW. PET/CT: form and function. Radiology 2007;242:360–85.PubMed

Hoffman EJ, Tornai MP, Janecek M, Patt BE, Iwanczyk JS. Intraoperative probes and imaging probes. Eur J Nucl Med 1999;26:913–35.PubMedCrossRef

Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med 2000;30:33–48.PubMedCrossRef

Schneebaum S, Even-Sapir E, Cohen M, Shacham-Lehrman H, Gat A, Brazovsky E, et al. Clinical applications of gamma-detection probes—radioguided surgery. Eur J Nucl Med 1999;26 Supp l:S26–35.PubMed

Piert M, Burian M, Meisetschlager G, Stein HJ, Ziegler S, Nahrig J, et al. Positron detection for the intraoperative localisation of cancer deposits. Eur J Nucl Med Mol Imaging 2007; DOI 10.1007/s00259-007-0430-5.

Meller B, Sahlmann C, Horstmann O, Gerl J, Baehre M, Meller J. Conventional gamma and high energy probe for radioguided dissection of metastases in a patient with recurrent thyroid carcinoma with ^99mTc-MIBI and ¹⁸F-FDG. Nuklearmedizin 2005;44:N23–5.PubMed

Meller B, Sommer K, Gerl J, von Hof K, Surowiec A, Richter E, et al. High energy probe for detecting lymph node metastases with ¹⁸F-FDG in patients with head and neck cancer. Nuklearmedizin 2006;45:153–9.PubMed

10.

Gulec SA, Daghighian F, Essner R. PET-probe: evaluation of technical performance and clinical utility of a handheld high-energy gamma probe in oncologic surgery. Ann Surg Oncol 2006; DOI 10.1245/ASO.2006.05.047.

11.

Essner R, Hsueh EC, Haigh PI, Glass EC, Huynh Y, Daghighian F. Application of an [¹⁸F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy. J Surg Res 2001;96:120–6.PubMedCrossRef

12.

Nwogu C, Fischer G, Tan D, Glinianski M, Lamonica D, Demmy T. Radioguided detection of lymph node metastasis in non-small cell lung cancer. Ann Thorac Surg 2006;82:1815–20.PubMedCrossRef

13.

Desai DC, Arnold M, Saha S, Hinkle G, Soble D, Fry J, et al. Correlative whole-body FDG-PET and intraoperative gamma detection of FDG distribution in colorectal cancer. Clin Positron Imaging 2000;3:189–96.PubMedCrossRef

14.

Zervos EE, Desai DC, DePalatis LR, Soble D, Martin EW. ¹⁸F-labeled fluorodeoxyglucose positron emission tomography-guided surgery for recurrent colorectal cancer: a feasibility study. J Surg Res 2001;97:9–13.PubMedCrossRef

15.

Yamamoto S, Higashi T, Matsumoto K, Senda M. Development of a positron-imaging detector with background rejection capability. Ann Nucl Med 2006;20:655–62.PubMed

16.

Yamamoto S, Matsumoto K, Sakamoto S, Tarutani K, Minato K, Senda M. An intra-operative positron probe with background rejection capability for FDG-guided surgery. Ann Nucl Med 2005;19:23–8.PubMedCrossRef

17.

Daghighian F, Mazziotta JC, Hoffman EJ, Shenderov P, Eshaghian B, Siegel S, et al. Intraoperative beta probe: a device for detecting tissue labeled with positron or electron emitting isotopes during surgery. Med Phys 1994;21:153–7.PubMedCrossRef

18.

Raylman RR. Performance of a dual, solid-state intraoperative probe system with ¹⁸F, ^99mTc, and ¹¹¹In. J Nucl Med 2001;42:352–60.PubMed

19.

Higashi T, Saga T, Ishimori T, Mamede M, Ishizu K, Fujita T, et al. What is the most appropriate scan timing for intraoperative detection of malignancy using ¹⁸F-FDG-sensitive gamma probe? Preliminary phantom and preoperative patient study. Ann Nucl Med 2004;18:105–14.PubMed

Title: PET probes and oncological surgery: a productive new marriage for nuclear medicine?
Author: Orazio Schillaci
Publication date: 01-10-2007
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 10/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-007-0482-6

At a glance: The STEP trials

Springer Medicine

PET probes and oncological surgery: a productive new marriage for nuclear medicine?

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2007

Diagnosis of endoneural sciatic nerve invasion by uterine cervical epidermoid cancer using [18F]FDG-PET/CT

Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma

Non-enhanced CT versus contrast-enhanced CT in integrated PET/CT studies for nodal staging of rectal cancer

Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study

Positron detection for the intraoperative localisation of cancer deposits